The Pharmacokinetics of Topical Levofloxacin 1.5% vs Topical Moxifloxacin 0.5%
Condition(s):EndophthalmitisLast Updated:October 14, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):EndophthalmitisLast Updated:October 14, 2020Unknown status
Condition(s):GASTRITISLast Updated:August 31, 2016Completed
Condition(s):Pneumonia, Bacterial; Community-acquiredLast Updated:April 12, 2016Completed
Condition(s):TBLast Updated:November 27, 2012Terminated
Condition(s):Myelodysplastic Syndromes; Acute Myeloid LeukemiaLast Updated:July 24, 2018Unknown status
Condition(s):Latent Tuberculosis Infection; Infection in Solid Organ Transplant RecipientsLast Updated:August 6, 2014Terminated
Condition(s):Prophylaxis; Stem Cell Transplant ComplicationsLast Updated:September 18, 2023Active, not recruiting
Condition(s):Helicobacter Pylori InfectionLast Updated:May 1, 2018Unknown status
Condition(s):Helicobacter Pylori InfectionLast Updated:August 31, 2012Terminated
Condition(s):Renal DiseasesLast Updated:June 8, 2011Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.